Tet2 deficiency leads to impaired homologous recombination DNA repair and decreased expression of breast cancer susceptibility genes (BRCAs), and the reduction in BRCA gene expression sensitizes tumor cells to PARPis (Gojo et al., 2017; Feng et al., 2019). Here, TET2 is linked to cancer.